Q-State Biosciences Revenue and Competitors

Boston, MA USA

Location

$22.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Q-State Biosciences's estimated annual revenue is currently $3.1M per year.(i)
  • Q-State Biosciences's estimated revenue per employee is $77,500
  • Q-State Biosciences's total funding is $22.5M.

Employee Data

  • Q-State Biosciences has 40 Employees.(i)
  • Q-State Biosciences grew their employee count by -20% last year.

Q-State Biosciences's People

NameTitleEmail/Phone
1
VP, Business Strategy & AnalyticsReveal Email/Phone
2
Associate Director BioinformaticsReveal Email/Phone
3
Sr. Director, Search & EvaluationReveal Email/Phone
4
Principal ScientistReveal Email/Phone
5
Executive AssistantReveal Email/Phone
6
Associate ScientistReveal Email/Phone
7
Research Associate II, Cell Biology DepartmentReveal Email/Phone
8
Research Associate IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Q-State Biosciences?

Q-State Biosciences was birthed in 2014 when we realized that human stem cell models combined with all-optical electrophysiology and functional genomics enables us to find new drugs for devastating disorders of the nervous system and to find evidence that a particular drug may be effective for an individual patient

keywords:N/A

$22.5M

Total Funding

40

Number of Employees

$3.1M

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Q-State Biosciences News

2022-03-30 - Search Continues for Improved Pain Therapeutics

Essentially, Q-State has an integrated platform for engineering disease-relevant in vitro cell models of pain, amassing neuronal activity...

2018-11-30 - Q-State Biosciences Closes Series A Financing

Q-State Biosciences, a Cambridge, MA-based provider of genomic services, closed an undisclosed Series A financing. Q-State Biosciences has also joined with Minneapolis-based Pairnomix, LLC, to create a precision medicine company focused on rare and devastating central nervous system (CNS) disea ...

2018-11-29 - Q-State Biosciences Closes Series A Financing

Q-State Biosciences, Inc. announced it has closed its Series A financing and has joined with Minneapolis-based Pairnomix, LLC to create the world-leading precision medicine company focused on rare and devastating central nervous system (CNS) diseases. Q-State is the only company now offering co ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5M40-7%N/A
#2
$4.6M4060%N/A
#3
$8M40-2%N/A
#4
$6.2M4067%N/A
#5
$3.5M4014%N/A